{
    "clinical_study": {
        "@rank": "80517", 
        "arm_group": [
            {
                "arm_group_label": "myo-inositol", 
                "arm_group_type": "Active Comparator", 
                "description": "1500 mg/day myoinositol"
            }, 
            {
                "arm_group_label": "metformin", 
                "arm_group_type": "Active Comparator", 
                "description": "1500 mg/day of metformin"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to compare the effects of six months treatment of two\n      insulin-lowering therapies on the clinical and endocrine-metabolic parameters in obese women\n      affected by polycystic ovary syndrome. The study group includes 40 patients, randomly\n      allocated to subgroup A (metformin 1500 mg/day) and subgroup B (myo-inositol 1500 mg/day).\n      The investigations include menstrual pattern and hirsutism score evaluation, hormonal\n      assays, oral glucose tolerance test, euglycemic hyperinsulinaemic clamp and lipid profile at\n      baseline and after six months of treatment."
        }, 
        "brief_title": "Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary Syndrome", 
        "condition": "Polycystic Ovary Syndrome", 
        "condition_browse": {
            "mesh_term": "Polycystic Ovary Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women with Polycystic Ovary Syndrome, diagnosed in accordance with Rotterdam\n             Consensus Conference Criteria 2003;\n\n          -  BMI>25 kg/m2;\n\n          -  age 18-35 years.\n\n        Exclusion Criteria:\n\n          -  pregnancy;\n\n          -  significant liver or renal impairment;\n\n          -  other hormonal dysfunction (hypothalamic, pituitary, thyroidal or adrenal causes for\n             the clinical signs);\n\n          -  neoplasms;\n\n          -  unstable mental illness;\n\n          -  diagnosis of diabetes mellitus or impaired glucose tolerance;\n\n          -  use of drugs able to interfere with gluco-insulinaemic metabolism for at least three\n             months prior to entering the study."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01791647", 
            "org_study_id": "000102011"
        }, 
        "intervention": [
            {
                "arm_group_label": "metformin", 
                "intervention_name": "metformin 1500 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "myo-inositol", 
                "intervention_name": "myoinositol 1500 mg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Inositol", 
                "Metformin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Polycystic ovary syndrome", 
            "myoinositol", 
            "metformin", 
            "glucose-insulinemic metabolism", 
            "menstrual pattern", 
            "insulin-lowering therapies"
        ], 
        "lastchanged_date": "February 12, 2013", 
        "location": {
            "contact": {
                "last_name": "Maurizio Guido, Medical Doctor", 
                "phone": "063057794"
            }, 
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00168"
                }, 
                "name": "Catholic University of Sacred Heart"
            }, 
            "investigator": {
                "last_name": "Maurizio Guido, Medical Doctor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Myo-inositol Versus Metformin: Effects of Six Months Treatment on Clinical, Endocrine and Metabolic Features in Obese Women With Polycystic Ovary Syndrome", 
        "overall_contact": {
            "last_name": "Antonio Lanzone, Professor", 
            "phone": "063057794"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Catholic University of Sacred Heart"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "number of cycles", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01791647"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Catholic University of the Sacred Heart", 
            "investigator_full_name": "Maurizio Guido", 
            "investigator_title": "principal investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Area under the curve insulin post oral glucose tolerance test (\u03bcUI/ML/180min), M value of euglycemic hyperinsulinaemic clamp(mg/kg/min).", 
            "measure": "effects of two therapies on glyco-insulinemic metabolism", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "source": "Catholic University of the Sacred Heart", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Catholic University of the Sacred Heart", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}